Bank of America reaffirmed their underperform rating on shares of UiPath (NYSE:PATH – Free Report) in a research report ...

Needham & Company LLC reiterated their hold rating on shares of UiPath (NYSE:PATH – Free Report) in a research note published on Thursday, Ratings reports. Several other research firms have also ...

UiPath's ARR to reach $1.816B in FY26 amid strong AI automation growth. Explore profitability, valuation, and challenges ...

US-based healthcare software provider Coronis Health has adopted the UiPath Platform from AI solution developer UiPath to ...

UiPath (PATH) has seen its stock hit an all-time low following a bleak revenue forecast issued as a part of its Q4 FY 2025 financial results.

On Friday, Mar. 14, 2025, the Cathie Wood-led Ark Invest made significant trades involving GitLab Inc GTLB, Intellia Therapeutics Inc NTLA, Prime Medicine Inc PRME, UiPath Inc PATH, Ibotta Inc ...

We recently published a list of Top 10 Stocks Everyone is Talking About. In this article, we are going to take a look at ...

Shares of UiPath Inc. fell sharply after hours on Wednesday after the business-automation software platform forecast sales for the year ahead that came in below Wall Street’s expectations ...

On Friday, BMO Capital Markets revised its price target for UiPath Inc. (NYSE:PATH) shares, reducing it to $11.50 from the ...

After months of waiting, Samsung has finally announced the One UI 7 rollout details. The brand has previously confirmed that the rollout will begin in April; now, it has revealed the exact rollout ...